This acquisition will add foliglurax in clinical phase II to its pipeline of innovative treatments for patients suffering from Parkinson's disease
Attachment

Lundbeck announced on 16 March 2018 that it will acquire Prexton Therapeutics for up to EUR 905 million.

Full press release

Find an actor

BioTaiwan 201819.07.2018

BioTaiwan Exhibition 2018 will be held from 19 to 22 July at the TWTC Nangang Exhibition Hall in Taipei, Taiwan.

GENOME JUMPER

Un jeu mobile pour explorer la diversité humaine.
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn